Newsletters
- Bay Area Newsletter
- Greater Los Angeles Newsletter
- Group Purchasing Newsletter
- Public Policy Newsletter
- Regulatory & Reimbursement Newsletter
- San Diego Newsletter
Regulatory & Reimbursement Newsletter
Regulatory and Reimbursement Newsletter | September 2025
September 8th, 2025
Biocom California submitted comments on the reauthorization of the Medical Device User Fee Amendments (MDUFA), FDA released its annual pharmaceutical quality report, and more.
Regulatory and Reimbursement Newsletter | August 2025
August 4th, 2025
Biocom California provided public comments at the FDA’s meeting on the reauthorization of PDUFA, the FDA announced a new CDER Director, and more.